Singapore, July 31 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Open-Label, Randomized, Crossover Study to Investigate the Relative Bioavailability of Abemaciclib (LY2835219) Test and Reference Formulations and an Alternate Administration Method, in Healthy Participants'. The following are the other relevant details related to the trial:
Therapeutic Area: Oncology (including Haematology-Oncology)
Trial Centre(s):
Lilly Centre for Pharmacology
Trial Status: NA
Principal Investigator(s):
Dr Noel Mathew Varghese
Published by HT Digital Content Services with permission from Health Daily Digest....